Komatsu Y - Search Results

1

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.

Wilke H, Muro K, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, Hironaka S, Sugimoto N, Lipatov O, Kim TY, Cunningham D, Rougier P, Komatsu Y, Ajani J, Emig M, Carlesi R, Ferry D, Chandrawansa K, Schwartz JD, Ohtsu A; RAINBOW Study Group. Wilke H, et al. Among authors: komatsu y. Lancet Oncol. 2014 Oct;15(11):1224-35. doi: 10.1016/S1470-2045(14)70420-6. Epub 2014 Sep 17. Lancet Oncol. 2014. PMID: 25240821 Clinical Trial.

2

A randomized phase II clinical trial of tailored CPT-11 + S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy.

Takahashi Y, Sakamoto J, Takeuchi T, Mai M, Kubota T, Kitajima M, Tanigawara Y, Komatsu Y, Toge T, Saji S. Takahashi Y, et al. Among authors: komatsu y. Jpn J Clin Oncol. 2004 Jun;34(6):342-5. doi: 10.1093/jjco/hyh067. Jpn J Clin Oncol. 2004. PMID: 15333687 Clinical Trial.

3

Phase II study of oral S-1 plus irinotecan in patients with advanced colorectal cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302.

Komatsu Y, Yuuki S, Fuse N, Takei M, Kato T, Miyagishima T, Kudo M, Kunieda Y, Tateyama M, Wakahama O, Meguro T, Ohizumi H, Watanabe M, Akita H, Sakata Y, Asaka M. Komatsu Y, et al. Jpn J Clin Oncol. 2005 Feb;35(2):88-9. doi: 10.1093/jjco/hyi025. Jpn J Clin Oncol. 2005. PMID: 15709093 Clinical Trial.

4

Pilot study of combination chemotherapy using irinotecan plus S-1 for metastatic pancreatic cancer.

Shitara K, Komatsu Y, Yuki S, Munakata M, Muto O, Shimaya S, Sakata Y. Shitara K, et al. Among authors: komatsu y. Oncology. 2008;75(1-2):67-70. doi: 10.1159/000151742. Epub 2008 Aug 28. Oncology. 2008. PMID: 18753799 Clinical Trial.

5

Multicenter Phase II study of cetuximab plus irinotecan in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin and fluoropyrimidines.

Tahara M, Shirao K, Boku N, Yamaguchi K, Komatsu Y, Inaba Y, Arai T, Mizunuma N, Satoh T, Takiuchi H, Nishina T, Sakata Y. Tahara M, et al. Among authors: komatsu y. Jpn J Clin Oncol. 2008 Nov;38(11):762-9. doi: 10.1093/jjco/hyn102. Epub 2008 Oct 4. Jpn J Clin Oncol. 2008. PMID: 18836202 Clinical Trial.

6

Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate.

Shirao K, Nishida T, Doi T, Komatsu Y, Muro K, Li Y, Ueda E, Ohtsu A. Shirao K, et al. Among authors: komatsu y. Invest New Drugs. 2010 Dec;28(6):866-75. doi: 10.1007/s10637-009-9306-9. Invest New Drugs. 2010. PMID: 19730791 Clinical Trial.

7

Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506.

Ishii H, Furuse J, Boku N, Okusaka T, Ikeda M, Ohkawa S, Fukutomi A, Hamamoto Y, Nakamura K, Fukuda H; JCOG Gastrointestinal Oncology Study Group. Ishii H, et al. Jpn J Clin Oncol. 2010 Jun;40(6):573-9. doi: 10.1093/jjco/hyq011. Epub 2010 Feb 25. Jpn J Clin Oncol. 2010. PMID: 20185458 Clinical Trial.

8

Multicenter phase II study of everolimus in patients with previously treated metastatic gastric cancer.

Doi T, Muro K, Boku N, Yamada Y, Nishina T, Takiuchi H, Komatsu Y, Hamamoto Y, Ohno N, Fujita Y, Robson M, Ohtsu A. Doi T, et al. Among authors: komatsu y. J Clin Oncol. 2010 Apr 10;28(11):1904-10. doi: 10.1200/JCO.2009.26.2923. Epub 2010 Mar 15. J Clin Oncol. 2010. PMID: 20231677 Clinical Trial.

9

Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for pre-treated metastatic colorectal cancer harboring wild-type KRAS.

Shitara K, Yokota T, Takahari D, Shibata T, Ura T, Komatsu Y, Yuki S, Yoshida M, Takiuchi H, Utsunomiya S, Yatabe Y, Muro K. Shitara K, et al. Among authors: komatsu y. Jpn J Clin Oncol. 2010 Jul;40(7):699-701. doi: 10.1093/jjco/hyq026. Epub 2010 Mar 18. Jpn J Clin Oncol. 2010. PMID: 20304778 Clinical Trial.

10

Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer.

Doi T, Boku N, Kato K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Sato A, Koizumi W, Mizunuma N, Takiuchi H. Doi T, et al. Among authors: komatsu y. Jpn J Clin Oncol. 2010 Oct;40(10):913-20. doi: 10.1093/jjco/hyq069. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462981 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,596 results

Search Page

Filters